Positive allosteric modulation of α4β2 nicotinic receptors potentiates some CNS effects of the α4β2 agonist, ABT-594

被引:0
|
作者
Franklin, S. R. [1 ]
Mohler, E. G. [1 ]
Komater, V. A. [1 ]
Robb, H. [1 ]
Radek, R. J. [1 ]
Rustay, N. R. [1 ]
Brown, J. W. [1 ]
Gopalakrishnan, M. [1 ]
Decker, M. W. [1 ]
Rueter, L. E. [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Neurosci Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/j.bcp.2009.06.083
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:921 / 921
页数:1
相关论文
共 50 条
  • [1] The role of neuronal nicotinic acetylcholine receptors in antinociception: Effects of ABT-594
    Decker, MW
    Curzon, P
    Holladay, MW
    Nikkel, AL
    Bitner, RS
    Bannon, AW
    Donnelly-Roberts, DL
    Puttfarcken, PS
    Kuntzweiler, TA
    Briggs, CA
    Williams, M
    Arneric, SP
    JOURNAL OF PHYSIOLOGY-PARIS, 1998, 92 (3-4) : 221 - 224
  • [2] Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice
    Decker, MW
    Bannon, AW
    Buckley, MJ
    Kim, DJB
    Holladay, MW
    Ryther, KB
    Lin, NH
    Wasicak, JT
    Williams, M
    Arneric, SP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 346 (01) : 23 - 33
  • [3] The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions
    Belluardo, N
    Mudò, G
    Caniglia, G
    Cheng, QZ
    Blum, M
    Fuxe, K
    NEUROREPORT, 1999, 10 (18) : 3909 - 3913
  • [4] Positive allosteric modulation of α4β2 nAChR agonist induced behaviour
    Rode, F.
    Munro, G.
    Holst, D.
    Nielsen, E. O.
    Troelsen, K. B.
    Timmermann, D. B.
    Ronn, L. C. B.
    Grunnet, M.
    BRAIN RESEARCH, 2012, 1458 : 67 - 75
  • [5] Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES
    Weltzin, Maegan M.
    Huang, Yanzhou
    Schulte, Marvin K.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 732 : 159 - 168
  • [6] Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors
    Kowal, Natalia M.
    Ahring, Philip K.
    Liao, Vivian W. Y.
    Indurti, Dinesh C.
    Harvey, Benjamin S.
    O'Connor, Susan M.
    Chebib, Mary
    Olafsdottir, Elin S.
    Balle, Thomas
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (14) : 2911 - 2925
  • [7] Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4ß2 Nicotinic Acetylcholine Receptors in Male Mice
    Hamouda, Ayman K.
    Jackson, Asti
    Bagdas, Deniz
    Damaj, M. Imad
    NICOTINE & TOBACCO RESEARCH, 2018, 20 (07) : 903 - 907
  • [8] Examining the effect of a substituted carbamate positive allosteric modulator on the (α4)3(β2)2 and (α4)2(β2)3 nicotinic acetylcholine receptors
    Gaona, Josue
    Mohiuddin, Musharaf
    Hamouda, Ayman K.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 395A - 395A
  • [9] Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors
    Alcaino, Constanza
    Musgaard, Maria
    Minguez, Teresa
    Mazzaferro, Simone
    Faundez, Manuel
    Iturriaga-Vasquez, Patricio
    Biggin, Philip C.
    Bermudez, Isabel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (02) : 551 - 562
  • [10] Targeting α4β2 Nicotinic Acetylcholine Receptors in Central Nervous System Disorders: Perspectives on Positive Allosteric Modulation as a Therapeutic Approach
    Grupe, Morten
    Grunnet, Morten
    Bastlund, Jesper Frank
    Jensen, Anders A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (03) : 187 - 200